212 related articles for article (PubMed ID: 17785779)
1. Invariant NKT cells biased for IL-5 production act as crucial regulators of inflammation.
Sakuishi K; Oki S; Araki M; Porcelli SA; Miyake S; Yamamura T
J Immunol; 2007 Sep; 179(6):3452-62. PubMed ID: 17785779
[TBL] [Abstract][Full Text] [Related]
2. CD1d-restricted NKT cells express a chemokine receptor profile indicative of Th1-type inflammatory homing cells.
Thomas SY; Hou R; Boyson JE; Means TK; Hess C; Olson DP; Strominger JL; Brenner MB; Gumperz JE; Wilson SB; Luster AD
J Immunol; 2003 Sep; 171(5):2571-80. PubMed ID: 12928408
[TBL] [Abstract][Full Text] [Related]
3. The complementarity determining region 2 of BV8S2 (V beta 8.2) contributes to antigen recognition by rat invariant NKT cell TCR.
Pyz E; Naidenko O; Miyake S; Yamamura T; Berberich I; Cardell S; Kronenberg M; Herrmann T
J Immunol; 2006 Jun; 176(12):7447-55. PubMed ID: 16751390
[TBL] [Abstract][Full Text] [Related]
4. CD1d-independent developmental acquisition of prompt IL-4 gene inducibility in thymus CD161(NK1)-CD44lowCD4+CD8- T cells is associated with complementarity determining region 3-diverse and biased Vbeta2/Vbeta7/Vbeta8/Valpha3.2 T cell receptor usage.
Chen YT; Kung JT
J Immunol; 2005 Nov; 175(10):6537-50. PubMed ID: 16272308
[TBL] [Abstract][Full Text] [Related]
5. Nonredundant roles for CD1d-restricted natural killer T cells and conventional CD4+ T cells in the induction of immunoglobulin E antibodies in response to interleukin 18 treatment of mice.
Yoshimoto T; Min B; Sugimoto T; Hayashi N; Ishikawa Y; Sasaki Y; Hata H; Takeda K; Okumura K; Van Kaer L; Paul WE; Nakanishi K
J Exp Med; 2003 Apr; 197(8):997-1005. PubMed ID: 12695491
[TBL] [Abstract][Full Text] [Related]
6. Up-regulation of CD1d expression restores the immunoregulatory function of NKT cells and prevents autoimmune diabetes in nonobese diabetic mice.
Falcone M; Facciotti F; Ghidoli N; Monti P; Olivieri S; Zaccagnino L; Bonifacio E; Casorati G; Sanvito F; Sarvetnick N
J Immunol; 2004 May; 172(10):5908-16. PubMed ID: 15128771
[TBL] [Abstract][Full Text] [Related]
7. Aging is associated with a rapid decline in frequency, alterations in subset composition, and enhanced Th2 response in CD1d-restricted NKT cells from human peripheral blood.
Jing Y; Gravenstein S; Chaganty NR; Chen N; Lyerly KH; Joyce S; Deng Y
Exp Gerontol; 2007 Aug; 42(8):719-32. PubMed ID: 17368996
[TBL] [Abstract][Full Text] [Related]
8. CD1d and invariant NKT cells at the human maternal-fetal interface.
Boyson JE; Rybalov B; Koopman LA; Exley M; Balk SP; Racke FK; Schatz F; Masch R; Wilson SB; Strominger JL
Proc Natl Acad Sci U S A; 2002 Oct; 99(21):13741-6. PubMed ID: 12368486
[TBL] [Abstract][Full Text] [Related]
9. Invariant and noninvariant natural killer T cells exert opposite regulatory functions on the immune response during murine schistosomiasis.
Mallevaey T; Fontaine J; Breuilh L; Paget C; Castro-Keller A; Vendeville C; Capron M; Leite-de-Moraes M; Trottein F; Faveeuw C
Infect Immun; 2007 May; 75(5):2171-80. PubMed ID: 17353286
[TBL] [Abstract][Full Text] [Related]
10. Cutting edge: invariant V alpha 14 NKT cells are required for allergen-induced airway inflammation and hyperreactivity in an experimental asthma model.
Lisbonne M; Diem S; de Castro Keller A; Lefort J; Araujo LM; Hachem P; Fourneau JM; Sidobre S; Kronenberg M; Taniguchi M; Van Endert P; Dy M; Askenase P; Russo M; Vargaftig BB; Herbelin A; Leite-de-Moraes MC
J Immunol; 2003 Aug; 171(4):1637-41. PubMed ID: 12902459
[TBL] [Abstract][Full Text] [Related]
11. Loss of IL-4 secretion from human type 1a diabetic pancreatic draining lymph node NKT cells.
Kent SC; Chen Y; Clemmings SM; Viglietta V; Kenyon NS; Ricordi C; Hering B; Hafler DA
J Immunol; 2005 Oct; 175(7):4458-64. PubMed ID: 16177088
[TBL] [Abstract][Full Text] [Related]
12. Activation of invariant NKT cells by the helminth parasite schistosoma mansoni.
Mallevaey T; Zanetta JP; Faveeuw C; Fontaine J; Maes E; Platt F; Capron M; de-Moraes ML; Trottein F
J Immunol; 2006 Feb; 176(4):2476-85. PubMed ID: 16456008
[TBL] [Abstract][Full Text] [Related]
13. Human invariant V alpha 24-J alpha Q TCR supports the development of CD1d-dependent NK1.1+ and NK1.1- T cells in transgenic mice.
Capone M; Cantarella D; Schümann J; Naidenko OV; Garavaglia C; Beermann F; Kronenberg M; Dellabona P; MacDonald HR; Casorati G
J Immunol; 2003 Mar; 170(5):2390-8. PubMed ID: 12594262
[TBL] [Abstract][Full Text] [Related]
14. A cell-type specific CD1d expression program modulates invariant NKT cell development and function.
Zimmer MI; Colmone A; Felio K; Xu H; Ma A; Wang CR
J Immunol; 2006 Feb; 176(3):1421-30. PubMed ID: 16424169
[TBL] [Abstract][Full Text] [Related]
15. A subset of NKT cells that lacks the NK1.1 marker, expresses CD1d molecules, and autopresents the alpha-galactosylceramide antigen.
Hameg A; Apostolou I; Leite-De-Moraes M; Gombert JM; Garcia C; Koezuka Y; Bach JF; Herbelin A
J Immunol; 2000 Nov; 165(9):4917-26. PubMed ID: 11046017
[TBL] [Abstract][Full Text] [Related]
16. IFN-gamma-producing human invariant NKT cells promote tumor-associated antigen-specific cytotoxic T cell responses.
Moreno M; Molling JW; von Mensdorff-Pouilly S; Verheijen RH; Hooijberg E; Kramer D; Reurs AW; van den Eertwegh AJ; von Blomberg BM; Scheper RJ; Bontkes HJ
J Immunol; 2008 Aug; 181(4):2446-54. PubMed ID: 18684935
[TBL] [Abstract][Full Text] [Related]
17. CD1d-restricted NKT cells: an interstrain comparison.
Hammond KJ; Pellicci DG; Poulton LD; Naidenko OV; Scalzo AA; Baxter AG; Godfrey DI
J Immunol; 2001 Aug; 167(3):1164-73. PubMed ID: 11466330
[TBL] [Abstract][Full Text] [Related]
18. Donor bone marrow type II (non-Valpha14Jalpha18 CD1d-restricted) NKT cells suppress graft-versus-host disease by producing IFN-gamma and IL-4.
Kim JH; Choi EY; Chung DH
J Immunol; 2007 Nov; 179(10):6579-87. PubMed ID: 17982047
[TBL] [Abstract][Full Text] [Related]
19. Expansion and hyperactivity of CD1d-restricted NKT cells during the progression of systemic lupus erythematosus in (New Zealand Black x New Zealand White)F1 mice.
Forestier C; Molano A; Im JS; Dutronc Y; Diamond B; Davidson A; Illarionov PA; Besra GS; Porcelli SA
J Immunol; 2005 Jul; 175(2):763-70. PubMed ID: 16002672
[TBL] [Abstract][Full Text] [Related]
20. CD1d-specific NK1.1+ T cells with a transgenic variant TCR.
Sköld M; Faizunnessa NN; Wang CR; Cardell S
J Immunol; 2000 Jul; 165(1):168-74. PubMed ID: 10861049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]